Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.
Akabani G, Reardon DA, Coleman RE, Wong TZ, Metzler SD, Bowsher JE, Barboriak DP, Provenzale JM, Greer KL, DeLong D, Friedman HS, Friedman AH, Zhao XG, Pegram CN, McLendon RE, Bigner DD, Zalutsky MR. Akabani G, et al. Among authors: zhao xg. J Nucl Med. 2005 Jun;46(6):1042-51. J Nucl Med. 2005. PMID: 15937318 Free article. Clinical Trial.
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report.
Bigner DD, Brown M, Coleman RE, Friedman AH, Friedman HS, McLendon RE, Bigner SH, Zhao XG, Wikstrand CJ, Pegram CN, et al. Bigner DD, et al. Among authors: zhao xg. J Neurooncol. 1995;24(1):109-22. doi: 10.1007/BF01052668. J Neurooncol. 1995. PMID: 8523067 Clinical Trial.
Tumor antigens in astrocytic gliomas.
Kurpad SN, Zhao XG, Wikstrand CJ, Batra SK, McLendon RE, Bigner DD. Kurpad SN, et al. Among authors: zhao xg. Glia. 1995 Nov;15(3):244-56. doi: 10.1002/glia.440150306. Glia. 1995. PMID: 8586461 Review.
Radioiodinated antibody targeting of the HER-2/neu oncoprotein.
Xu FJ, Yu YH, Bae DS, Zhao XG, Slade SK, Boyer CM, Bast RC Jr, Zalutsky MR. Xu FJ, et al. Among authors: zhao xg. Nucl Med Biol. 1997 Jul;24(5):451-9. doi: 10.1016/s0969-8051(97)00065-6. Nucl Med Biol. 1997. PMID: 9290082
Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.
Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS, Thorstad WL, McLendon RE, Bigner SH, Zhao XG, Pegram CN, Wikstrand CJ, Herndon JE 2nd, Vick NA, Paleologos N, Cokgor I, Provenzale JM, Zalutsky MR. Bigner DD, et al. Among authors: zhao xg. J Clin Oncol. 1998 Jun;16(6):2202-12. doi: 10.1200/JCO.1998.16.6.2202. J Clin Oncol. 1998. PMID: 9626222 Clinical Trial.
Intrathecal 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial results.
Brown MT, Coleman RE, Friedman AH, Friedman HS, McLendon RE, Reiman R, Felsberg GJ, Tien RD, Bigner SH, Zalutsky MR, Zhao XG, Wikstrand CJ, Pegram CN, Herndon JE 2nd, Vick NA, Paleologos N, Fredericks RK, Schold SC Jr, Bigner DD. Brown MT, et al. Among authors: zhao xg. Clin Cancer Res. 1996 Jun;2(6):963-72. Clin Cancer Res. 1996. PMID: 9816257 Clinical Trial.
194 results